pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Cesarean Section Skin Prep - Does Skin Preparation Pattern Affect Skin Bacterial Burden
Status: RECRUITING
Conditions: Cesarean Section Complications|Wound Infection
Interventions: PROCEDURE: Skin preparation patterns with ChloraPrep 2 x 26 mL single
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes
Status: COMPLETED
Conditions: Exposure to Secondhand Smoke in Neonatal Infants
Interventions: BEHAVIORAL: Motivational Interviewing plus Incentives|BEHAVIORAL: Conventional Care (CC)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Different Dermatological Approaches the Treatment of Melasma
Status: UNKNOWN
Conditions: Melasma
Interventions: DEVICE: chemicalpeeling|DEVICE: cryopeeling|COMBINATION_PRODUCT: microneedling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
Status: COMPLETED
Conditions: Kidney Transplantation
Interventions: DRUG: mycophenolate mofetil|DRUG: mycophenolate mofetil|DRUG: anti-IL-2R|DRUG: methylprednisolone|DRUG: cyclosporine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial
Status: COMPLETED
Conditions: Drug-induced Nausea and Vomiting
Interventions: DRUG: Ondansetron|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Direct Diagnosis of Disseminated Lyme Borreliosis.
Status: UNKNOWN
Conditions: Lyme Disease
Interventions: PROCEDURE: Targeted proteomics in skin +/- cerebrospinal or synovial fluid to diagnose disseminated Lyme disease
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Dyspnea Self-Management: Internet or Face-to-Face
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: BEHAVIORAL: Internet DSMP|BEHAVIORAL: Face-to-Face Dyspnea Self-management|BEHAVIORAL: Attention Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Status: UNKNOWN
Conditions: HIV-1|HIV Infections
Interventions: OTHER: VircoType HIV-1 genotypic interpretation|OTHER: Local Expert Review of HIV Genotypic resistance testing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD
Status: WITHDRAWN
Conditions: COPD
Interventions: DRUG: Spiolto® Respimat® (Tiotropium / Olodaterol)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room
Status: RECRUITING
Conditions: Communication Research|Communication, Multidisciplinary
Interventions: BEHAVIORAL: StOP?-protocol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
Status: RECRUITING
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Gemcitabine|DRUG: Nadunolimab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Belinostat in Treating Patients With Myelodysplastic Syndromes
Status: COMPLETED
Conditions: de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Secondary Myelodysplastic Syndromes
Interventions: DRUG: belinostat
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Acupuncture Treatment on Motor Dysfunction in Stroke Patients
Status: ACTIVE_NOT_RECRUITING
Conditions: Stroke|Motor Disorders
Interventions: OTHER: Acupuncture Treatment|OTHER: Rehabilitation Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
Status: COMPLETED
Conditions: Hematological Malignancies|Neutropenia|Fever
Interventions: DRUG: Pts. w/ neutropenic fever associated w/ hematologic malignancy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: BIOLOGICAL: ONO-4685|BIOLOGICAL: Placebo|BIOLOGICAL: KLH|BIOLOGICAL: KLH, ONO-4685|BIOLOGICAL: KLH, placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations
Status: WITHDRAWN
Conditions: Asthma|Status Asthmaticus
Interventions: DEVICE: Bilevel Positive Airway Pressure (BiPAP) (Trilogy BiPAP, Philips Respironics)|OTHER: Standard care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
Status: TERMINATED
Conditions: Neoplasms Malignant
Interventions: DRUG: dalotuzumab|DRUG: MK-0752|DRUG: ridaforolimus|DRUG: MK-2206
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver Disease
Status: UNKNOWN
Conditions: Alcoholic Liver Diseases
Interventions: DIETARY_SUPPLEMENT: formulation containing S-Adenosyl methionine and choline|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Glucagon like peptide-1|DRUG: Adenosine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT
Status: COMPLETED
Conditions: Osteoarthritis, Knee
Interventions: DRUG: Instruction on analgesic use for pain relief (acetaminophen and NSAIDs)|OTHER: Neuromuscular exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase II Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis
Status: NOT_YET_RECRUITING
Conditions: Atopic Dermatitis
Interventions: DRUG: AK120
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: New Acute Treatment for Stroke - The Effect of Remote PERconditioning
Status: COMPLETED
Conditions: Acute Stroke
Interventions: DRUG: Actilyse|PROCEDURE: Thrombolysis + remote perconditioning
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status: WITHDRAWN
Conditions: Lung Cancer
Interventions: DRUG: gefitinib|DRUG: sirolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children
Status: TERMINATED
Conditions: Atopic Dermatitis
Interventions: DRUG: pimecrolimus active cream|OTHER: placebo base cream
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
Status: COMPLETED
Conditions: Fungal Keratitis
Interventions: DRUG: Natamycin 5%|DRUG: Voriconazole|PROCEDURE: Corneal de-epithelialization
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD
Status: RECRUITING
Conditions: Post Traumatic Stress Disorder
Interventions: BEHAVIORAL: Therapist-supported internet-delivered prolonged exposure|BEHAVIORAL: Therapist-supported internet-delivered CBT
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Use of Post-operative NPWT Dressing in the Prevention of Infectious Complications After Ostomy Reversal Surgery
Status: COMPLETED
Conditions: Stoma Ileostomy|Surgical Wound|Negative Pressure Wound Therapy|Postoperative Wound Infection
Interventions: DEVICE: Postoperative Negative Pressure Wound Therapy KCI NANOVA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Adolescent and Adult Patients in an Emergency Department
Status: COMPLETED
Conditions: Asthma Exacerbation|COPD Exacerbation|Lower Respiratory Disease|Pneumonia
Interventions: DEVICE: ResAppDx v.20
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Status: SUSPENDED
Conditions: Medulloblastoma, Childhood
Interventions: DRUG: CX 4945
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries
Status: COMPLETED
Conditions: Lower Extremity Surgery|Bunion|Metatarsophalangeal Fushion|Midfoot Fusion|Hindfoot Fushion|Total Ankle Arthroplasty
Interventions: DRUG: Exparel|DRUG: Bupivacaine Hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue
Status: NOT_YET_RECRUITING
Conditions: Irritable Bowel Syndrome
Interventions: OTHER: Low- FODMAPdiet group intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Status: TERMINATED
Conditions: Aplastic Anemia|Pure Red Cell Aplasia|Diamond Blackfan Anemia
Interventions: DRUG: Daclizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Emotional Freedom Technique on Depression, Anxiety and Distress of Individuals With Multiple Sclerosis
Status: COMPLETED
Conditions: Multiple Sclerosis|Anxiety|Depressive Symptoms|Psychiatric Nursing
Interventions: BEHAVIORAL: Emotional Freedom Technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Status: COMPLETED
Conditions: Myositis|Myasthenia Gravis
Interventions: DRUG: Rituximab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison Between Low Pressure Versus High Pressure Laparoscopic Cholecystectomy
Status: COMPLETED
Conditions: Cholelithiasis
Interventions: PROCEDURE: Laparoscopic cholecystectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Status: UNKNOWN
Conditions: Acute Myeloid Leukemia
Interventions: DRUG: Idarubicin|DRUG: Cytarabine|DRUG: Cyclophosphamide|DRUG: Physician-Directed Regimens without Cyclophosphamide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS Patients
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: DEVICE: "RehaCom" computer-based cognitive training in addition to Conventional physical therapy program|OTHER: Conventional physical therapy program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study of Vimseltinib for Tenosynovial Giant Cell Tumor
Status: ACTIVE_NOT_RECRUITING
Conditions: Tenosynovial Giant Cell Tumor|Pigmented Villonodular Synovitis|Giant Cell Tumor of Tendon Sheath|Tenosynovial Giant Cell Tumor, Diffuse|Tenosynovial Giant Cell Tumor, Localized
Interventions: DRUG: vimseltinib|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
Status: COMPLETED
Conditions: Arthritis, Psoriatic
Interventions: DRUG: placebo|DRUG: ustekinumab 45 mg|DRUG: ustekinumab 90 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs
Status: UNKNOWN
Conditions: Disorders Related to Lung Transplantation|Graft Failure
Interventions: PROCEDURE: EVLP-DCD Group
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
Status: COMPLETED
Conditions: Researcher-Subject Relations
Interventions: DRUG: Ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma
Status: COMPLETED
Conditions: Metastatic Renal Cell Carcinoma
Interventions: DRUG: Tc 99m EC20
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds
Status: RECRUITING
Conditions: Wound
Interventions: DEVICE: MaxioCel|DEVICE: AquaCel Extra
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prevention of Incontinence-associated Dermatitis
Status: RECRUITING
Conditions: Incontinence-associated Dermatitis
Interventions: OTHER: ESENTA™ Skin Barrier Spray (ConvaTec, UK)|OTHER: Hydrophobes Basisgel DAC
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
Status: RECRUITING
Conditions: Extensive Stage Lung Small Cell Cancer
Interventions: DRUG: Serplulimab|RADIATION: Chest Radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
Status: COMPLETED
Conditions: Coronary Artery Disease
Interventions: DRUG: Dabigatran|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Investigating Affective Attitude Question-behaviour Effects on Intention to Become an Organ Donor
Status: COMPLETED
Conditions: Organ Donation
Interventions: BEHAVIORAL: Question-behaviour effect (for affective attitudes)|BEHAVIORAL: Question-behaviour effect (negatively-worded attitudes)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: The Effect of Complementary Care Model on Patient Outcomes
Status: RECRUITING
Conditions: Nursing Caries|Music Therapy|Aromatherapy|Preoperative Care|Postoperative Care|Complementary Therapies
Interventions: OTHER: music therapy|OTHER: aromatherapy|OTHER: Progressive Relaxation Exercises|OTHER: Hand massage
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
Status: COMPLETED
Conditions: Waldenström Macroglobulinemia
Interventions: DRUG: Daratumumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease
Status: UNKNOWN
Conditions: Crohn's Disease
Interventions: DRUG: VSL#3
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
Status: WITHDRAWN
Conditions: Head Neck Cancer|Radiation Neuropathy|Pain, Neuropathic
Interventions: DRUG: Gabapentin|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
Status: COMPLETED
Conditions: Severe Hepatic Impairment|Normal Hepatic Function
Interventions: DRUG: enzalutamide
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Status: COMPLETED
Conditions: Breast Carcinoma|Cervical Carcinoma|Colorectal Carcinoma|Health Status Unknown|Human Papillomavirus Infection|Malignant Neoplasm
Interventions: OTHER: Informational Intervention
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effectiveness of a Triclosan Containing Toothpaste in Maintaining Periodontal Health in a Type 2 Diabetic Population
Status: COMPLETED
Conditions: Periodontitis
Interventions: DRUG: Triclosan/copolymer/fluoride|DRUG: Fluoride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: AspireAssist for Palliative Venting Gastrostomy in Malignant Bowel Obstruction Patients
Status: WITHDRAWN
Conditions: Malignant Small Bowel Obstruction|Malignant Gastric Outlet Obstruction
Interventions: DEVICE: AspireAssist device|DEVICE: Standard decompressive PEG tube|OTHER: gastric outlet obstruction scoring system (GOOSS) questionnaire|OTHER: Modified Gastroparesis Cardinal Symptom Index (GCSI) questionnaire|OTHER: Patient satisfaction and ease of use survey
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
Status: RECRUITING
Conditions: Heart Failure|Heart Failure With Reduced Ejection Fraction|Heart Failure With Mid Range Ejection Fraction
Interventions: DRUG: Optimal treatment
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
Status: COMPLETED
Conditions: Diabetic Foot Ulcer
Interventions: DRUG: Chinese herbal medicine (Radix Rehmanniae and Radix Astragali)|DRUG: Placebo comparator
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
Status: RECRUITING
Conditions: Ankylosing Spondylitis
Interventions: DRUG: Recombinant humanized IL-17A Monoclonal Antibody（JS005）|DRUG: Placebo（JS005）
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
Status: COMPLETED
Conditions: Head and Neck Cancer
Interventions: DRUG: azacitidine|DRUG: liothyronine sodium|RADIATION: iodine I 131
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
Status: COMPLETED
Conditions: Cognitive Deficits in Schizophrenia
Interventions: DRUG: ABT-126|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC.
Status: COMPLETED
Conditions: Non-small Cell Lung Cancer
Interventions: OTHER: PET/CT|PROCEDURE: EBUS-TBNA, EUS-NA|PROCEDURE: TEMLA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Status: UNKNOWN
Conditions: Non-small Cell Lung Cancer
Interventions: DRUG: apatinib|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy
Status: UNKNOWN
Conditions: Kidney Failure, Chronic|Covid19|Vaccine Reaction|Vaccine Adverse Reaction
Interventions: DIAGNOSTIC_TEST: Immune response|OTHER: Solicited common and expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic or pain medications and unsolicited adverse events and serious adverse events
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
Status: COMPLETED
Conditions: Alcoholism|Depression
Interventions: DRUG: Ebixa (memantine hydrochloride)|DRUG: Cipralex (escitalopram)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: The BSHAPE Intervention Program for Safety and Health of Survivors of Cumulative Trauma
Status: COMPLETED
Conditions: Violence|Cumulative Trauma|HIV Risk|Stress|Mental Health|Reproductive Health|Empowerment
Interventions: BEHAVIORAL: The BSHAPE Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Status: COMPLETED
Conditions: Leukemia|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Myeloproliferative Diseases|Non-Hodgkins Lymphoma|Hodgkins Lymphoma|Multiple Myeloma|Myelodysplastic Syndrome
Interventions: DRUG: Fludarabine monophosphate|DRUG: Busulfan|PROCEDURE: Stem Cell Infusion|DRUG: Tacrolimus|DRUG: Methotrexate|DRUG: G-CSF
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Ketosis on Muscle Kinetics and Signaling During Critical Illness.
Status: NOT_YET_RECRUITING
Conditions: Intensive Care Unit Acquired Weakness|Critical Illness
Interventions: DIETARY_SUPPLEMENT: KetoneAid KE4 Pro Monoester|DIETARY_SUPPLEMENT: Maltodextrin and fat-based placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Status: COMPLETED
Conditions: Atopic Dermatitis|Eczema
Interventions: DRUG: Bermekimab Monoclonal Antibody|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)
Status: RECRUITING
Conditions: Acute Myocarditis
Interventions: DRUG: Methylprednisolone 125 MG|OTHER: IV saline solution 0.9%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Status: COMPLETED
Conditions: Enterovirus|Rhinovirus
Interventions: DRUG: Nitazoxanide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of CORT118335 on Olanzapine-Induced Weight Gain
Status: COMPLETED
Conditions: Antipsychotic-induced Weight Gain
Interventions: DRUG: Olanzapine|DRUG: CORT118335|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
Status: COMPLETED
Conditions: Raynaud Disease|Raynaud's Phenomenon
Interventions: DEVICE: Manual blood pressure cuff inflation over brachial artery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Pain Management Education on The Mothers in Newborn
Status: COMPLETED
Conditions: Pain|Procedural Pain|Infant ALL
Interventions: PROCEDURE: Providing education and brochures on non-pharmacological methods that can be applied during the heel blood collection process
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.
Status: COMPLETED
Conditions: Multiple Myeloma de Novo Treatment
Interventions: DRUG: Thalidomide, Dexamethasone|DRUG: Vincristin , Adriamycin, Dexamethasone = VAD|DRUG: Thalidomide, melphalan, endoxan, dexamethasone (MCDex-Thal)|DRUG: melphalan, endoxan, dexamethasone (MCDex)|DRUG: Thalidomide, Dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Active and PRT on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fascitis
Status: RECRUITING
Conditions: Gait|Pain|Plantar Fascitis
Interventions: OTHER: Active release technique|OTHER: Positional release technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Status: UNKNOWN
Conditions: HIV|Pregnancy
Interventions: DRUG: Raltegravir|DRUG: Lopinavir/Ritonavir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
Status: COMPLETED
Conditions: Rosacea
Interventions: DRUG: Minocycline hydrochloride capsules|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
Status: ACTIVE_NOT_RECRUITING
Conditions: Prostate Cancer Adenocarcinoma
Interventions: RADIATION: 30Gy (Gray) planning target volume (PTV)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients
Status: COMPLETED
Conditions: Liver Transplantation
Interventions: DRUG: Cyclosporine (Sandimmun® i.v.)|DRUG: Cyclosporine (Sandimmun® Optoral)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of an Innovative Balance Training Programme in Enhancing Postural Control and Reducing Falls in Patients With Parkinson's Disease
Status: UNKNOWN
Conditions: Parkinson's Disease
Interventions: OTHER: experimental|OTHER: control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Contribution of the Ultrasound Tracking and the Positioning of the Distal End During the Implantation of Implantable Chamber or Long-lasting Venous Catheter
Status: WITHDRAWN
Conditions: Echocardiography|Implantable Chamber
Interventions: OTHER: Adult patients who are candidates for a CAP or long-term central catheter placement
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Exploring the Cortical Hemodynamic Variability of Prefrontal iTBS: a Concurrent TBS/fNIRS Study
Status: RECRUITING
Conditions: Healthy
Interventions: DEVICE: Intermittent theta burst stimulation (iTBS)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Obstructive Sleep Apnea, Retinal Vein Occlusion, Retinal Artery Occlusion
Status: UNKNOWN
Conditions: Retinal Vascular Occlusion
Interventions: DEVICE: Watchpat 100
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Status: RECRUITING
Conditions: Colorectal Cancer|CRC|Pancreatic Ductal Adenocarcinoma|PDAC|Gastrointestinal Cancer|Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: DRUG: RMC-6236|DRUG: mFOLFOX6 regimen|DRUG: bevacizumab|DRUG: mFOLFIRINOX regimen|DRUG: cetuximab|DRUG: gemcitabine|DRUG: nab-paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal Women
Status: COMPLETED
Conditions: Postmenopausal Syndrome|Hypertension
Interventions: BEHAVIORAL: Modified Relaxation (MR)|BEHAVIORAL: Lifestyle Education (LE)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
Status: RECRUITING
Conditions: Ischemic Stroke, Acute
Interventions: DRUG: Intravenous tenecteplase|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase I Study of GFH312 in Healthy Chinese Subjects
Status: COMPLETED
Conditions: Healthy Volunteer
Interventions: DRUG: GFH312 100 mg|DRUG: GFH312 200 mg|DRUG: GFH312 120mg|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma
Status: COMPLETED
Conditions: Follicular Lymphoma
Interventions: BIOLOGICAL: Y90 Ibritumomab Tiuxetan RIT
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery
Status: RECRUITING
Conditions: Scoliosis
Interventions: DRUG: Lidocaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells
Status: COMPLETED
Conditions: Change in Bone Mineral Density|Change in Bone Marrow Fat Content
Interventions: DRUG: Rosiglitazone|DRUG: Placebo pill
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: NHFOV vs NIPPV vs nCPAP in Preterm Infants With Respiratory Distress Syndrome
Status: UNKNOWN
Conditions: Preterm Infant
Interventions: OTHER: nCPAP|OTHER: NIPPV|OTHER: NHFOV
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Status: COMPLETED
Conditions: Sleep Apnea, Obstructive|Diabetes Mellitus
Interventions: DEVICE: Continuous positive airway pressure|DEVICE: Sham continuous positive airway pressure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
Status: COMPLETED
Conditions: Colonic Diseases
Interventions: DEVICE: PillCam COLON|PROCEDURE: Standard colonoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury.
Status: NOT_YET_RECRUITING
Conditions: Abdominal Muscles
Interventions: OTHER: Vojta Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Vitamin A Absorption From Fortified Bouillon
Status: RECRUITING
Conditions: Healthy Volunteers|Vitamin A
Interventions: DIETARY_SUPPLEMENT: Unfortified bouillon plus vitamin A in oil|DIETARY_SUPPLEMENT: Bouillon fortified with vitamin A #1 plus unfortified oil|DIETARY_SUPPLEMENT: Bouillon fortified with vitamin A #2 plus unfortified oil
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
Status: COMPLETED
Conditions: AIDS
Interventions: BIOLOGICAL: HIV Vaccine 732462|BIOLOGICAL: Placebo vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents
Status: COMPLETED
Conditions: Schizophrenia and Disorders With Psychotic Features|Mood Disorders|Neurotic Disorders|Personality Disorders|Substance-Related Disorders
Interventions: BEHAVIORAL: CHIMPS intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine
Status: COMPLETED
Conditions: Respiratory Tract Infections
Interventions: DRUG: Paracetamol 500 mg/Phenylephrine 5 mg tablets|DRUG: Paracetamol 1000 mg/Phenylephrine 10 mg sachet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
Status: RECRUITING
Conditions: Obesity|Blood Glucose, High
Interventions: BEHAVIORAL: Micronutrient-dense plant-rich Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)
Status: TERMINATED
Conditions: Follicular Lymphoma|Lymphoma, Large B-Cell, Diffuse
Interventions: DRUG: Idasanutlin|DRUG: Obinutuzumab|DRUG: Venetoclax|DRUG: Rituximab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer
Status: TERMINATED
Conditions: Pregnancy
Interventions: PROCEDURE: Active acupuncture|PROCEDURE: Sham acupuncture
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of the Most Commonly Used Physiotherapeutic Treatments for Acute Lower Limb Fatigue in Athletes
Status: COMPLETED
Conditions: Lower Limb Injury
Interventions: DIAGNOSTIC_TEST: State-Trait Anxiety Questionnaire|DIAGNOSTIC_TEST: Rating of Perceived Exertion|DIAGNOSTIC_TEST: Motor coordination tests|PROCEDURE: Physiotherapeutic intervention|OTHER: Data Analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)
Status: COMPLETED
Conditions: Knee Osteoarthritis
Interventions: DEVICE: CR 500™ SINGLE-DOSE GEL
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction
Status: COMPLETED
Conditions: Myocardial Infarction
Interventions: DEVICE: Mobile-phone based patient support|DEVICE: e-diary
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Clinical trial: An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis
Status: TERMINATED
Conditions: Amyotrophic Lateral Sclerosis
Interventions: DRUG: sNN0029
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
Status: NOT_YET_RECRUITING
Conditions: Neonatal Hyperbilirubinemia
Interventions: DRUG: Zinc sulfate|DRUG: Ursodeoxycholic acid
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Over-the-scope Clip Versus Through-the-scope Clip for Endoscopic Hemostasis of High Risk Bleeding Peptic Ulcers
Status: UNKNOWN
Conditions: Bleeding Peptic Ulcer
Interventions: DEVICE: OTSC|DEVICE: TTS clip
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: LY2409021|DRUG: Placebo|DRUG: Metformin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Upper Limb Botulinum Toxin Injection Combined With Self Rehabilitation
Status: COMPLETED
Conditions: Self Rehabilitation Combined With BTI on Upper Limb
Interventions: OTHER: self rehabilitation of upper limb in experimental group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Impact of a PCT(Procalcitonin) Rapid Test -Based Approach on ATB (Antibiotics) Use in Children With Fever Without Source
Status: COMPLETED
Conditions: Fever Without Source
Interventions: DIAGNOSTIC_TEST: DIAFEVER algorithm
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: DIAGNOSTIC
Clinical trial: Pregabalin and Post-thoracotomy Pain
Status: COMPLETED
Conditions: Chronic Pain
Interventions: DRUG: Pregabalin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection
Status: COMPLETED
Conditions: Hepatitis C, Chronic
Interventions: DRUG: TG-2349|DRUG: Ribavirin|DRUG: Interferon Alfa-2a
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors
Status: TERMINATED
Conditions: Neoplasm
Interventions: DRUG: Tusamitamab ravtansine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Status: UNKNOWN
Conditions: Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Interventions: DRUG: MRG003
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of a Tailored Multidimensional Intervention on the Care Burden Among Family Caregivers of Stroke Survivors
Status: COMPLETED
Conditions: Stroke|Caregiver Burden|Caregiver Burnout
Interventions: BEHAVIORAL: Tailored Multidimensional Intervention. the tailored intervention will be implemented through 6 months using a multidimensional approach (skill building, psychoeducation and peer support).
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Clinical Trial to Evaluate the Efficacy of the Morley Medical Sepsis (MMS) Software Device in Predicting Sepsis in Adult Patients Using Artificial Intelligence (AI) Machine Learning Algorithms
Status: UNKNOWN
Conditions: Sepsis
Interventions: DEVICE: Morley Medical Sepsis Software Device
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC